IMAC Holdings, Inc. Hosts Hall of Fame Athlete Panel at the Evoke Conference to Launch Whole Food Supplement Partnership
2022年10月21日 - 11:30PM
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the
“Company”), announces today it is partnering with Evoke
Chiropractic Coaching to educate and offer its new organic, whole
food supplements to its network of physician offices. The
partnership begins with an evening panel of athletes presenting
during the Evoke 3rd Annual Conference in St. Louis, Missouri.
The panel is composed of Hall of Fame shortstop
and 1982 World Series Champion Ozzie Smith, Hall of Fame
thoroughbred jockey and 2017 Fitness Muscle Mania winner Rosemary
Homeister, NBA veteran and former VP of the NBA Players Association
Maurice Evans, and collegiate All-American and 2015 Super Bowl
champion Sylvester Williams.
Dr. Ben Lerner, IMAC Holdings Chief Operating
Officer, will lead the panel discussion of health, diet, and
supplementation in front of an audience of doctors, students, and
business attendees. Participants will have the opportunity to
provide the IMAC supplement line in their offices and a portion of
every sale will be contributed to serve Evoke’s mission.
Evoke Chiropractic aims to assist minority
Chiropractors in building a viable business and sustainable
practice. Founding Partners Dr. Edgar Everett III, Dr. Xavier
Tipler, and Dr. Frank Vaught Jr., established the Evoke Conference
to increase visibility of the chiropractic profession by sharing
the importance of diversity and inclusion within the industry.
“Presenting with this elite group of athletes,
community, and business leaders is a unique and powerful
opportunity to support the Evoke mission,” said Dr. Lerner. “We are
very excited to provide this level of support to doctors through
our new seed-to-bottle formulations as another advanced way for
IMAC to create better health in communities around the
country.”
About IMAC Holdings, Inc.
IMAC Holdings owns and manages health and
wellness centers that deliver sports medicine, orthopedic care, and
restorative joint and tissue therapies for movement restricting
pain and neurodegenerative diseases. IMAC is comprised of
three business segments: outpatient medical centers, The Back
Space, and a clinical research division. With treatments to address
both young and aging populations, IMAC Holdings owns or
manages outpatient medical clinics that deliver regenerative
rehabilitation services as a minimally invasive approach to acute
and chronic musculoskeletal and neurological health problems.
IMAC’s The Back Company retail spinal health and wellness treatment
centers deliver chiropractic care within Walmart locations. IMAC’s
research division is currently conducting a Phase I clinical trial
evaluating a mesenchymal stem cell therapy candidate for
bradykinesia due to Parkinson’s disease. For more information
visit www.imacholdings.com.
###
Safe Harbor Statement
This press release contains forward-looking
statements. These forward-looking statements, and terms such as
“anticipate,” “expect,” “believe,” “may,” “will,” “should” or other
comparable terms, are based largely
on IMAC's expectations and are subject to a number of
risks and uncertainties, certain of which are
beyond IMAC's control. Actual results could differ
materially from these forward-looking statements as a result of,
among other factors, risks and uncertainties associated with its
ability to maintain and grow its business, variability of operating
results, its ability to maintain and enhance its brand, its
development and introduction of new products and services, the
successful integration of acquired companies, technologies and
assets, marketing and other business development initiatives,
competition in the industry, general government regulation,
economic conditions, dependence on key personnel, the ability to
attract, hire and retain personnel who possess the skills and
experience necessary to meet customers’ requirements, and its
ability to protect its intellectual
property. IMAC encourages you to review other factors
that may affect its future results in its registration statement
and in its other filings with the Securities and Exchange
Commission. In light of these risks and uncertainties, there can be
no assurance that the forward-looking information contained in this
press release will in fact occur.
IMAC Press Contact:Laura Fristoelfristoe@imacrc.com
IMAC (NASDAQ:IMACW)
過去 株価チャート
から 5 2024 まで 6 2024
IMAC (NASDAQ:IMACW)
過去 株価チャート
から 6 2023 まで 6 2024